Table 3 Decision change at multidisciplinary team (MDT)

From: The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2− early breast cancer

Clinical risk assignment

Molecular risk assignment

n

Decision change

Clinically low risk

MammPrint low risk

36

0

Clinically low risk

MammaPrint high risk

8

4

Clinically high risk

MammPrint low risk

21

10

Clinically high risk

MammaPrint high risk

10

0

Back to article page